Literature DB >> 23887281

Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer's disease.

Yong Ji1, Mengyuan Liu, Ya Ruth Huo, Shuling Liu, Zhihong Shi, Shuai Liu, Thomas Wisniewski, Jinhuan Wang.   

Abstract

The relationship between the apolipoprotein E (ApoE) ε4 genotype and an increased risk of developing Alzheimer's disease (AD) has been well established in Caucasians but is less established among other ethnicities. ApoE ε4 has also been associated with several other neurological disorders. Whether ApoΕ4 ε4 is a risk factor for frontotemporal dementia (FTD) remains controversial. This study examined 432 patients with AD, 62 with FTD, and 381 sex- and age-matched controls. The ApoE ε4 allele frequency was significantly increased among patients in the AD and FTD groups compared with controls. The frequency of the ApoΕ ε4 allele was 24.86% in late-onset AD (p < 0.01), 18.02% in early-onset AD (p < 0.01), 16.13% in FTD (p < 0.01), and 7.34% in controls. ApoΕ ε4 prevalence was similar in the FTD and AD groups. The present study suggests that the ApoE ε4 allele is a risk factor for both disorders.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887281      PMCID: PMC4068025          DOI: 10.1159/000350872

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  43 in total

1.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

Review 2.  Alzheimer's disease and frontotemporal dementia: prospects of a tailored therapy?

Authors:  Jürgen Götz; Lars M Ittner; Nicole Schonrock
Journal:  Med J Aust       Date:  2006-10-02       Impact factor: 7.738

Review 3.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

4.  APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians.

Authors:  Oye Gureje; Adesola Ogunniyi; Olusegun Baiyewu; Brandon Price; Frederick W Unverzagt; Rebecca M Evans; Valerie Smith-Gamble; Kathleen A Lane; Sujuan Gao; Kathleen S Hall; Hugh C Hendrie; Jill R Murrell
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

Review 5.  Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis.

Authors:  Sheila Crean; Alex Ward; Catherine J Mercaldi; Jenna M Collins; Michael N Cook; Nicole L Baker; H Michael Arrighi
Journal:  Dement Geriatr Cogn Disord       Date:  2010-12-01       Impact factor: 2.959

6.  Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia.

Authors:  L Gustafson; M Abrahamson; A Grubb; K Nilsson; G Fex
Journal:  Dement Geriatr Cogn Disord       Date:  1997 Jul-Aug       Impact factor: 2.959

Review 7.  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

8.  The APOE gene locus in frontotemporal dementia and primary progressive aphasia.

Authors:  Davide Seripa; Alessandra Bizzarro; Francesco Panza; Adele Acciarri; Fabio Pellegrini; Alberto Pilotto; Carlo Masullo
Journal:  Arch Neurol       Date:  2011-05

Review 9.  A clinical approach to early-onset inheritable dementia.

Authors:  Brian S Rogers; Carol F Lippa
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-05       Impact factor: 2.035

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  11 in total

Review 1.  Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.

Authors:  Tien-Phat V Huynh; Albert A Davis; Jason D Ulrich; David M Holtzman
Journal:  J Lipid Res       Date:  2017-02-27       Impact factor: 5.922

2.  Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.

Authors:  Elizabeth E Blue; Joshua C Bis; Michael O Dorschner; Debby W Tsuang; Sandra M Barral; Gary Beecham; Jennifer E Below; William S Bush; Mariusz Butkiewicz; Carlos Cruchaga; Anita DeStefano; Lindsay A Farrer; Alison Goate; Jonathan Haines; Jim Jaworski; Gyungah Jun; Brian Kunkle; Amanda Kuzma; Jenny J Lee; Kathryn L Lunetta; Yiyi Ma; Eden Martin; Adam Naj; Alejandro Q Nato; Patrick Navas; Hiep Nguyen; Christiane Reitz; Dolly Reyes; William Salerno; Gerard D Schellenberg; Sudha Seshadri; Harkirat Sohi; Timothy A Thornton; Otto Valadares; Cornelia van Duijn; Badri N Vardarajan; Li-San Wang; Eric Boerwinkle; Josée Dupuis; Margaret A Pericak-Vance; Richard Mayeux; Ellen M Wijsman
Journal:  Dement Geriatr Cogn Disord       Date:  2018-02-27       Impact factor: 2.959

3.  Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China.

Authors:  Ke-Liang Chen; Yi-Min Sun; Yan Zhou; Qian-Hua Zhao; Ding Ding; Qi-Hao Guo
Journal:  Psychiatr Genet       Date:  2016-06       Impact factor: 2.458

Review 4.  Glial contributions to neurodegeneration in tauopathies.

Authors:  Cheryl E G Leyns; David M Holtzman
Journal:  Mol Neurodegener       Date:  2017-06-29       Impact factor: 14.195

5.  Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.

Authors:  Wen-Hua Su; Zhi-Hong Shi; Shu-Ling Liu; Xiao-Dan Wang; Shuai Liu; Yong Ji
Journal:  Oncotarget       Date:  2017-07-04

6.  Identification of a Novel Hemizygous SQSTM1 Nonsense Mutation in Atypical Behavioral Variant Frontotemporal Dementia.

Authors:  Lin Sun; Zhouyi Rong; Wei Li; Honghua Zheng; Shifu Xiao; Xia Li
Journal:  Front Aging Neurosci       Date:  2018-02-06       Impact factor: 5.750

7.  Uncoupling protein 4 (UCP4) gene variability in neurodegenerative disorders: further evidence of association in Frontotemporal dementia.

Authors:  Alberto Montesanto; Paolina Crocco; Serena Dato; Silvana Geracitano; Francesca Frangipane; Rosanna Colao; Raffaele Maletta; Giuseppe Passarino; Amalia C Bruni; Giuseppina Rose
Journal:  Aging (Albany NY)       Date:  2018-11-13       Impact factor: 5.682

8.  Association between the COMTVal158Met Genotype and Alzheimer's Disease in the Han Chinese Population.

Authors:  Yong Ji; Zhihong Shi; Mengyuan Liu; Shuai Liu; Shuling Liu; Jinhuan Wang
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-01-31

9.  Association of apolipoprotein E genotype with outcome in hospitalized ischemic stroke patients.

Authors:  Yajing Zhang; Shuling Liu; Wei Yue; Zhihong Shi; Yalin Guan; Mingzi Li; Yong Ji; Xin Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  The Impact of the COVID-19 Pandemic on Alzheimer's Disease and Other Dementias.

Authors:  Jinghuan Gan; Shuai Liu; Hao Wu; Zhichao Chen; Min Fei; Junying Xu; Yuchao Dou; Xiaodan Wang; Yong Ji
Journal:  Front Psychiatry       Date:  2021-07-14       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.